These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38914691)

  • 1. Author Correction: On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation.
    Wang X; Wang Y; Chen J; Wang Q; Liu Z; Yin Y; Yang T; Shen T; Sa Y
    Sci Rep; 2024 Jun; 14(1):14531. PubMed ID: 38914691
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation.
    Wang X; Wang Y; Chen J; Wang Q; Liu Z; Yin Y; Yang T; Shen T; Sa Y
    Sci Rep; 2024 May; 14(1):10114. PubMed ID: 38698063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the Mechanism of Wogonin, a Natural Flavonoid, on the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Integrating Network Pharmacology and In Vitro Validation.
    Cui L; Zeng Z; Wang X; Yuan T; Wang C; Liu D; Guo J; Chen Y
    Curr Issues Mol Biol; 2023 Jan; 45(1):555-570. PubMed ID: 36661523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Pharmacology for Analyzing the Key Targets and Potential Mechanism of Wogonin in Gliomas.
    Wang Z; Cheng L; Shang Z; Li Z; Zhao Y; Jin W; Li Y; Su F; Mao X; Chen C; Zhang J
    Front Pharmacol; 2021; 12():646187. PubMed ID: 33897434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibitory effect of wogonin on human colorectal cancer cell SW480 based on network pharmacology].
    Li YP; Gong YT; Wang JX; Cheng YR; Zhang X; Wang J; Xu WJ; Dong L
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1772-1778. PubMed ID: 32489060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding the Mechanism of Shen Qi Sha Bai Decoction in Treating Acute Myeloid Leukemia Based on Network Pharmacology and Molecular Docking.
    Jia G; Jiang X; Li Z; Ding X; Lei L; Xu S; Gao N
    Front Cell Dev Biol; 2021; 9():796757. PubMed ID: 34988084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Key Target and Molecular Mechanism of the Volatile Component of
    Zhu G; Zhang J; Yang Y; Zhang H; Jin W; Su F; Liang J; Wang K; Zhang J; Chen C
    Front Pharmacol; 2021; 12():650780. PubMed ID: 33981230
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of modified Liangge San in treatment of acute respiratory distress syndrome based on network pharmacology and experimental validation].
    Li Q; Wang MM; Nie SN; Sun HJ; Tang C; Sun ZR
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(24):6753-6762. PubMed ID: 36604925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK/p38 MAPK signaling pathway.
    Wu Y; Fang Y; Li Y; Au R; Cheng C; Li W; Xu F; Cui Y; Zhu L; Shen H
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117323. PubMed ID: 37852337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Author Correction: Exploring the mechanism of action of Sparganii Rhizoma-Curcumae Rhizoma for in treating castration-resistant prostate cancer: a network-based pharmacology and experimental validation study.
    Wu L; Chen H; Long Y; Qiu J; Dai X; You X; Li T
    Sci Rep; 2024 Mar; 14(1):5103. PubMed ID: 38429329
    [No Abstract]   [Full Text] [Related]  

  • 11. Network Pharmacology and Experimental Validation to Explore the Mechanism of Qing-Jin-Hua-Tan-Decoction Against Acute Lung Injury.
    Xiao S; Liu L; Sun Z; Liu X; Xu J; Guo Z; Yin X; Liao F; Xu J; You Y; Zhang T
    Front Pharmacol; 2022; 13():891889. PubMed ID: 35873580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation.
    Xu X; Zhang X; Zhang Y; Yang L; Liu Y; Huang S; Lu L; Kong L; Li Z; Guo Q; Zhao L
    Sci Rep; 2021 Jun; 11(1):12746. PubMed ID: 34117343
    [No Abstract]   [Full Text] [Related]  

  • 13. Apoptotic Mechanism of Human Leukemia K562/A02 Cells Induced by Magnetic Ferroferric Oxide Nanoparticles Loaded with Wogonin.
    Peng MX; Wang XY; Wang F; Wang L; Xu PP; Chen B
    Chin Med J (Engl); 2016 Dec; 129(24):2958-2966. PubMed ID: 27958228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wogonin, a Bioactive Ingredient from Huangqi Guizhi Formula, Alleviates Discogenic Low Back Pain via Suppressing the Overexpressed NGF in Intervertebral Discs.
    Li J; Duan W; Chai S; Luo Y; Ma Y; Yang N; Liu M; He W
    Mediators Inflamm; 2023; 2023():4436587. PubMed ID: 36860203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin combined with arsenic trioxide in the treatment of acute myeloid leukemia: network pharmacology analysis and experimental validation.
    Zeng YJ; Liu F; Wu M; Wu XP; Zhang DL; Yuan QQ; Zhou L; Wu ZH
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):219-230. PubMed ID: 36352148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wogonin, a natural and biologically-active flavonoid, influences a murine WEHI-3 leukemia model in vivo through enhancing populations of T- and B-cells.
    Lin CC; Lin JJ; Wu PP; Lu CC; Chiang JH; Kuo CL; Ji BC; Lee MH; Huang AC; Chung JG
    In Vivo; 2013; 27(6):733-8. PubMed ID: 24292576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.
    Xu X; Zhang X; Zhang Y; Yang L; Liu Y; Huang S; Lu L; Kong L; Li Z; Guo Q; Zhao L
    Sci Rep; 2017 Feb; 7():39950. PubMed ID: 28150717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the mechanism of physcion-1-O-β-D-monoglucoside against acute lymphoblastic leukaemia based on network pharmacology and experimental validation.
    Liu J; Yang Y; Zeng Y; Qin X; Guo L; Liu W
    Heliyon; 2023 Mar; 9(3):e14009. PubMed ID: 36923879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a Lung Cancer Discriminative Model Based on an Optimized Support Vector Machine Algorithm and Study of Key Targets of Wogonin in Lung Cancer.
    Wang L; Zhang J; Shan G; Liang J; Jin W; Li Y; Su F; Ba Y; Tian X; Sun X; Zhang D; Zhang W; Chen CL
    Front Pharmacol; 2021; 12():728937. PubMed ID: 34630106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis.
    Yao J; Zhao L; Zhao Q; Zhao Y; Sun Y; Zhang Y; Miao H; You QD; Hu R; Guo QL
    Cell Death Dis; 2014 Jun; 5(6):e1283. PubMed ID: 24901054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.